Lippincott, Williams & Wilkins, Journal of Clinical Psychopharmacology, 4(29), p. 387-390, 2009
DOI: 10.1097/jcp.0b013e3181aba5a5
Full text: Unavailable
Olfactory dysfunction, impaired odor identification in particular, is known to occur in Alzheimer disease (AD). The entorhinal cortex and the olfactory bulb, critical areas for olfactory function, are rich in acetylcholine, the neurotransmitter implicated in AD pathology and treatment. In view of the common anatomical substrate, we aimed to determine whether performance on an olfaction test can be used as a clinical marker for monitoring the efficacy of donepezil in elderly people with AD. ; 75493